Citigroup
RDHL

Citigroup’s Redhill Biopharma RDHL Stock Holding History

Citigroup’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5
Closed -$166 – 5817
2023
Q4 		$166 Buy
+5
New +$102 ﹤0.01% 5542
2023
Q1 		– Sell
-1
Closed -$146 – 5798
2022
Q4 		$146 Hold
1
– – ﹤0.01% 5621
2022
Q3 		$1K Sell
1
-4
-80% -$3.48K ﹤0.01% 5672
2022
Q2 		$4K Buy
5
+4
+400% +$5.49K ﹤0.01% 5707
2022
Q1 		$3K Hold
1
– – ﹤0.01% 5972
2021
Q4 		$4K Sell
1
-1
-50% -$4K ﹤0.01% 5686
2021
Q3 		$11K Sell
2
-1
-33% -$6.78K ﹤0.01% 5447
2021
Q2 		$19K Buy
3
+2
+200% +$13.8K ﹤0.01% 5339
2021
Q1 		$5K Sell
1
-1
-50% -$8.39K ﹤0.01% 5902
2020
Q4 		$15K Buy
2
+1
+100% +$8.99K ﹤0.01% 6802
2020
Q3 		$8K Hold
1
– – ﹤0.01% 6773
2020
Q2 		$5K Buy
+1
New +$6.89K ﹤0.01% 7274
2016
Q1 		– Hold
0
– – – 7711
2015
Q4 		– Hold
0
– – – 7810
2015
Q2 		– Hold
0
– – – 7706
2015
Q1 		– Hold
0
– – – 7381
2014
Q2 		– Hold
0
– -$1K – 7278
2014
Q1 		– Hold
0
– – – 6885

Other funds holding RDHL

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup's RDHL Position: Q1 2024 in Review

Citigroup sold out of Redhill Biopharma (RDHL) in Q1 2024, closing a stake of 5 shares — an estimated $166 sold.

Citigroup first reported a position in RDHL in Q2 2020 and held it in 12 quarters. The position peaked at $19K in Q2 2021. 15 funds tracked by Wall St. Rank hold RDHL as of Q1 2024.

  • Citigroup reported no remaining Redhill Biopharma position as of Q1 2024 after selling out during the quarter.
  • Citigroup sold 5 Redhill Biopharma shares in Q1 2024, an estimated $166.
  • Citigroup first reported a position in Redhill Biopharma in Q2 2020 and held it in 12 quarters.
  • Citigroup's Redhill Biopharma position peaked at $19K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.